Experiment 520809
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | GIACCONE,G: HUIZING,M: HUININK,WB: KOOLEN,M: POSTMUS,P: VAN KRALINGEN,K: VAN ZANDWIJK,N: VERMORKEN,J: BEIJNEN,J: DALESIO,O: PINEDO,H: VEENHOF,C:. (1994). PRELIMINARY RESULTS OF TWO DOSE-FINDING STUDIES OF PACLITAXEL (TAXOL) AND CARBOPLATIN IN NON-SMALL CELL LUNG AND OVARIAN CANCERS: A EUROPEAN CANCER CENTRE EFFORT.. 21(5) |
| Amount utilized | |
| Compound isolated | |
| Disease | PHASE III STUDY OF CMPD GIVEN WITH CARBOPLATIN (300 MG/M2) IN TREATING NON-SMALL-CELL LUNG CANCER AND OVARIAN CANCER IN 33 AND 11 PATIENTS, RESPECTIVELY. SIDE EFFECTS INCLUDE NEUTROPENIA, ALOPECIA, VOMITING, SKIN REACTIONS, ARTHRALGIA AND MYALGIA. STUDY CONTINUES TO ASSESS MAXIMUM TOLERATED DOSE. |
| Dose amount | 175.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |